Blossom Pro: Research Briefing #1 – 5-MeO-DMT, Group psychedelic therapy, and personality changes
Explore the latest in psychedelic research: cost-effective group therapy models, unique effects of 5-MeO-DMT, and personality changes post-experience.
Explore the latest in psychedelic research: cost-effective group therapy models, unique effects of 5-MeO-DMT, and personality changes post-experience.
A battle of Compass Pathways (Guy Goodwin) vs the MIND Foundation (Max Wolff). The need for psychotherapy or just psychological support.
This is all the other psychedelic research that came out in December 2023. These papers don’t (yet) have their own page in our database.
November’s psychedelic research saw advances in ayahuasca formulations and intriguing survey findings on naturalistic use. The month also featured complex mechanisms and tracking psychedelic states via heart rate dynamics.
This is all the other psychedelic research that came out in November 2023. These papers don’t (yet) have their own page in our database.
The latest psychedelic research from October 2023, extended DMT, survey data on extended difficulties, and new trial results.
Tommaso Barba, a visionary in psychedelic research, advances knowledge and accessibility, bridging diverse fields for a brighter future.
PsychedelicsEUROPE is shaping the European psychedelic landscape, influencing policies, and addressing mental health crises. Their MEP action group aims to accelerate EU regulatory changes.
This is all the other psychedelic research that came out in October 2023. These papers don’t (yet) have their own page in our database.
The psychedelic research that was published in September 2023. From new trials to guidelines. Psychedelic studies that were impactful this month.